Business description: Pfizer Inc

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:

- primary care products (52.3%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;

- specialty care products (25.6%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;

- oncology products (19.9%);

- other (2.2%).

Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (33.8%).

Sales by Activity: Pfizer Inc

Fiscal Period: December20192020202120222023

Global Biopharmaceuticals Business (Biopharma)

39.42B 41.91B 79.56B 98.99B 57.19B

Upjohn

10.23B - - - -

Other business activities

2.1B - 1.73B 1.34B 1.31B
See all business segments

Geographical breakdown of sales: Pfizer Inc

Fiscal Period: December20192020202120222023

United States

23.85B 21.71B 29.75B 42.47B 27.09B

Emerging Markets

12.73B 8.37B 20.7B 20.1B 12B

Developed Europe

8.7B 7.79B 18.34B 21.98B 11.65B

International

6.46B 4.04B 12.51B 15.78B 7.76B
See all geographic segments

Managers: Pfizer Inc

Director TitleAgeSince
Chief Executive Officer 63 2018-12-31
Director of Finance/CFO 60 2022-05-01
Chief Tech/Sci/R&D Officer 56 -
Compliance Officer 64 2013-11-30
Chief Tech/Sci/R&D Officer - 2006-12-31
See PFIZER INC governance

Members of the board: Pfizer Inc

Manager TitleAgeSince
Director/Board Member 67 2007-08-31
Director/Board Member 72 2011-12-11
Director/Board Member 61 2013-09-26
Chairman 63 2019-12-31
Director/Board Member 65 2014-06-25
Director/Board Member 67 2015-06-24
Director/Board Member 65 2017-02-22
Director/Board Member 72 2018-03-04
Director/Board Member 52 2019-06-26
Director/Board Member 60 2020-02-26
Composition of the Board of Directors

Shareholders: Pfizer Inc

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
9.15 %
518,535,151 9.15 % 13 752 M $
BlackRock Advisors LLC
5.84 %
330,938,055 5.84 % 8 776 M $
290,484,350 5.126 % 7 704 M $
Charles Schwab Investment Management, Inc.
2.743 %
155,459,101 2.743 % 4 123 M $
Wellington Trust Co., NA
2.47 %
139,990,889 2.47 % 3 713 M $
NameEquities%Valuation
Caixa DTVM SA
0.001335 %
302,642 0.001335 % 2 M $
Itaú Unibanco SA
0.001164 %
263,920 0.001164 % 2 M $
BRAM - Bradesco Asset Management SA DTVM
0.000225 %
51,024 0.000225 % 338 646 $
Bank of America Merrill Lynch Banco Multiplo SA
0.000016 %
3,600 0.000016 % 23 893 $
BTG Pactual WM Gestão de Recursos Ltda.
0.000011 %
2,438 0.000011 % 16 181 $
List of PFIZER INC shareholders

Holdings: Pfizer Inc

NameEquities%Valuation
661,709,7647.31%3,080,808,171 $
29,243,04263.92%1,531,443,488 $
3,658,3611.54%452,795,341 $
3,457,8155.03%60,892,122 $
5,376,3447.62%56,021,504 $
22,032,04010.51%39,657,672 $
115,928,8039.03%34,820,375 $
562,6260.75%30,426,814 $
9,549,7615.88%27,082,072 $
1,875,0001.23%21,693,750 $

Company details: Pfizer Inc

Pfizer Inc.

66 Hudson Boulevard East

10001-2192, New York

+212 733 2323

http://www.pfizer.com
address Pfizer Inc

Group companies: Pfizer Inc

NameCategory and Sector
Pharmaceuticals: Major
Pharmaceuticals: Major
Medical Distributors
Pfizer Overseas LLC
Pfizer Luxembourg SARL
Medical Distributors
See all subsidiaries

Other Pharmaceuticals

Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
-3.00%-3.88%+11.41%+246.24% 760B
-0.70%+1.98%-1.12%-6.67% 376B
-1.50%-11.35%-34.17%+73.38% 349B
-0.30%+1.19%+9.22%+33.23% 340B
-1.11%+1.90%+29.62%-13.94% 264B
-2.14%+0.93%+20.40%+39.70% 229B
-1.67%-4.89%-34.40%+6.68% 210B
-2.46%-1.51%+8.62%+20.43% 210B
-1.16%-0.81%+0.72%+30.02% 157B
Average -1.56%-1.83%+1.15%+47.67% 321.55B
Weighted average by Cap. -1.73%-2.25%+2.30%+82.03%
See all sector performances